Jules A. Maltz - 15 Dec 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
10%+ Owner
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
15 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 15:50:45 UTC
Previous filing
30 Nov 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +2,449 +13% 20,863 15 Dec 2022 Direct F1
holding HIMS Class A Common Stock 125,000 15 Dec 2022 Held by Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018
holding HIMS Class A Common Stock 53,974 15 Dec 2022 Held by Institutional Venture Partners XV Executive Fund, L.P. F2
holding HIMS Class A Common Stock 10,147,758 15 Dec 2022 Held by Institutional Venture Partners XV, L.P. F2
holding HIMS Class A Common Stock 10,201,746 15 Dec 2022 Held by Institutional Venture Partners XVI, L.P. F2
holding HIMS Class A Common Stock 7,346 15 Dec 2022 Held by Institutional Venture Management XV, LLC F3
holding HIMS Class A Common Stock 7,345 15 Dec 2022 Held by Institutional Venture Management XVI, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -5 -11% $0.000000 39 15 Dec 2022 Class A Common Stock 5 Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -218 -10% $0.000000 1,961 15 Dec 2022 Class A Common Stock 218 Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -2,226 -10% $0.000000 20,041 15 Dec 2022 Class A Common Stock 2,226 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
F3 Mr. Maltz is a managing director of IVM XV, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and IVM XVI, which isthe general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVM XV, IVM XVI, IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
F4 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.